» Authors » Victoria Villalta-Gil

Victoria Villalta-Gil

Explore the profile of Victoria Villalta-Gil including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 242
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pandina G, Busner J, Kempf L, Fallon J, Alphs L, Acosta M, et al.
Innov Clin Neurosci . 2024 Mar; 21(1-3):52-60. PMID: 38495603
The 1983 Orphan Drug Act in the United States (US) changed the landscape for development of therapeutics for rare or orphan diseases, which collectively affect approximately 300 million people worldwide,...
2.
Cunningham-Erves J, Kusnoor S, Villalta-Gil V, Stallings S, Ichimura J, Israel T, et al.
BMC Med Res Methodol . 2022 Sep; 22(1):248. PMID: 36153481
Background: Previous studies support cultural tailoring of recruitment materials as a strategy to promote the enrollment of minoritized groups in clinical trials. However, there is a lack of guidance for...
3.
Busner J, Pandina G, Domingo S, Berger A, Acosta M, Fisseha N, et al.
Innov Clin Neurosci . 2022 Jan; 18(10-12):15-22. PMID: 35096477
Objective: The International Society of CNS Clinical Trials Methodology (ISCTM) Working Group on Rare Disease/Orphan Drug Development is dedicated to improving and streamlining trials to best develop new treatments for...
4.
Canedo J, Villalta-Gil V, Grijalva C, Schlundt D, Jerome R, Wilkins C
Hisp Health Care Int . 2022 Jan; 20(4):238-247. PMID: 35018873
Interest in the return of research results has been increasing; however, little is known about how Hispanics/Latinos perceive and value receiving results. This study examined differences among Hispanics/Latinos by education...
5.
Kusnoor S, Villalta-Gil V, Michaels M, Joosten Y, Israel T, Epelbaum M, et al.
BMC Med Res Methodol . 2021 Mar; 21(1):44. PMID: 33673809
Background: Racial and ethnic minorities are often underrepresented in clinical trials, threatening the generalizability of trial results. Several factors may contribute to underrepresentation of minorities in clinical trials, including lack...
6.
Gentry C, Espiritu E, Schorn M, Hallmark B, Bryan M, Prather P, et al.
Curr Pharm Teach Learn . 2021 Jan; 13(2):169-176. PMID: 33454075
Background Interprofessional education (IPE) and training in community settings is not commonly described in the literature. Studies primarily focus on clinical education of interprofessional teams in clinical practice and primary...
7.
Lahey B, Hinton K, Meyer F, Villalta-Gil V, Van Hulle C, Applegate B, et al.
Personal Neurosci . 2020 Jun; 3:e5. PMID: 32524066
Predictive associations were estimated between socioemotional dispositions measured at 10-17 years using the Child and Adolescent Dispositions Scale (CADS) and future individual differences in white matter microstructure measured at 22-31...
8.
Cunningham-Erves J, Villalta-Gil V, Wallston K, Boyer A, Wilkins C
J Clin Transl Sci . 2019 Oct; 3(2-3):113-119. PMID: 31660234
Objective: Lack of trust toward medical research is a major barrier to research participation, particularly among some population groups. Valid measures of trust are needed to develop appropriate interventions. The...
9.
Wilkins C, Mapes B, Jerome R, Villalta-Gil V, Pulley J, Harris P
Health Aff (Millwood) . 2019 Mar; 38(3):399-407. PMID: 30830824
There is growing public demand that research participants receive all of their results, regardless of whether clinical action is indicated. Instead of the standard practice of returning only actionable results,...
10.
Hinton K, Lahey B, Villalta-Gil V, Meyer F, Burgess L, Chodes L, et al.
Neuroimage Clin . 2019 Feb; 22:101705. PMID: 30753960
Increasing data indicate that prevalent forms of psychopathology can be organized into second-order dimensions based on their correlations, including a general factor of psychopathology that explains the common variance among...